Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CODAMINE

HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

Standard Dose
5MG/5ML;25MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CODAMINE is listed in Drugs@FDA under application 075103 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE Form and strength SYRUP;ORAL - 5MG/5ML;25MG/5ML Sponsor ALPHARMA US PHARMS Submission history Latest submission status date: 2000-09-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview CODAMINE is listed in Drugs@FDA under application 075103 (ANDA). Marketing status: Discontinued Active ingredient HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE Form and strength SYRUP;ORAL - 5MG/5ML;25MG/5ML Sponsor ALPHARMA US PHARMS Submission history Latest submission status date: 2000-09-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
CODAMINE (HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline